Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04 Novembre 2024 - 10:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of November 2024
Commission File Number: 001-40614
PainReform LTD.
(Translation of registrant’s name into English)
65 Yigal Alon St., Tel Aviv 6744316
Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form
40-F.
Form 20-F ☒ Form 40-F ☐
On November 4, 2024, PainReform Ltd. (the “Company”) convened an Extraordinary General Meeting of Shareholders
(the “Extraordinary General Meeting”). However, the Extraordinary General Meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Company’s Extraordinary General Meeting will be reconvened on
Monday, November 11, 2024 at 3:00 p.m., Israel time, at the offices of the Company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, at 7 Metsada St., B.S.R Tower 4, Bnei Brak, Israel.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
INTERCURE LTD.
|
|
|
|
|
Date: November 4, 2024
|
/s/ Ehud Geller
|
|
|
Ehud Geller
Interim Chief Executive Officer
|
Grafico Azioni PainReform (NASDAQ:PRFX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni PainReform (NASDAQ:PRFX)
Storico
Da Nov 2023 a Nov 2024
